• Korea Science and Art Forum
• /
• v.31
• /
• pp.355-365
• /
• 2017

The future population of Korea is expected to reach the second highest level in the world by 2060 for the elderly. It is because of the rapid development of low fertility and medical technology. The burden of society for the elderly is expected to increase steadily. The elderly person firstly appears functional disorder. They have low ability in memory and in cognitive will be. Their activities are therefore limited. And economic production capacity is sharply reduced. Self-sufficiency is a difficult situation. They need help in economic and social aspects. Products for them need research and development. The elderly have a Mild Cognitive Impairment(MCI) stage with poor cognitive abilities. It is effective to combine pharmacological and non-pharmacological treatment methods for people with mild cognitive impairment. The effects of non-pharmacological treatments on music have been proven. This paper is a study on the appearance from the viewpoint of design in the development of ancillary instruments using music therapy techniques with Digital Convergence. For this study, we investigated the preference for external appearance of mild cognitive impairment. Two times surveys were conducted. As a result, the design of home care product for the hard cognitive impaired was different from that of a conventional game machine or set top box. It should be designed according to the user's special circumstances. They are memory and cognitive abilities. Products that meet physical and mental changes must be developed.

• Journal of Applied Biological Chemistry
• /
• v.53 no.4
• /
• pp.239-247
• /
• 2010

Helicobacter pylori (H. pylori) is the main causal bacteria occurring stomach diseases such as gastritis and gastric ulcer. These bacteria are found in most adults' stomach. Especially, 60~90% of H. pylori is found in Korean stomach. As a lot of curing methods have been applied to remove H. pylori and certain effects have been done but it's impossible to remove it perfectly with the existing medicines for curing. Therefore, it's very urgent to develop a certain substance showing more excellent effect than the existing medicines. In this study, it wasfound that organic acids can be accessed easily, inserted into mouth for curing and has excellent sterilizing effect among the substances showing excellent antibiotic power. Among them, acetic acid showed the most excellent effect. To confirm the refraining power against H. pylori, we performed tests through in vitro contact testing methods by concentration and tsta. In the result, H. pylori were terminated perfectly in the solution of acetic acid more than 0.3% within 1 minute. With a base of the result of In vitro test, It was performed in vivo test. As the results, H. pyloriwere terminated perfectly on 0.2% solution of acetic acid from the result of confirming through urease test, ELISA method and RT-PCR. Therefore, the result of this research will be very useful information in developing the functional foodstuffs using acetic acid in order to terminate H. pylori on the people's stomach, who suffers from H. pylori.

• Journal of Digital Convergence
• /
• v.12 no.6
• /
• pp.655-667
• /
• 2014

This paper has identified five major categories of the T2D patients' concerns based on an online forum where the patients voluntarily verbalized their naturally occurring emotional reactions and concerns related to T2D. We have emphasized the fact that the lexical and phrasal analysis brought to the forefront the prevailing negative reactions and desires for clear information, professional advice, and emotional support. This study used lexical and phrasal analysis based on text-mining tools to estimate the potential of using a large sample of patient conversation of a specific disease posted on the internet for clinical features and patients' emotions. As a result, the study showed that quantitative analysis based on text-mining is a viable method of generalizing the psychological concerns and features of T2D patients.

• Journal of the Korea Institute of Information and Communication Engineering
• /
• v.21 no.9
• /
• pp.1752-1760
• /
• 2017

One of the treatments and preventions of strokes such as ischemic stroke is to increase cerebral blood flow. This aims to minimize the size of the stroke by increasing the quantity of blood to the cerebral region circuitously. Several ways to increase cerebral blood flow are a therapy though drugs and through surgery. However these invasive method giving a burden to the patient, the problem of inducing a number of complications were noted. In this thesis, we propose a non-invasive brain flow enhancer to complement the disadvantages of such invasive treatment methods. To compensate for the shortcomings of the existing devices, the patient's blood pressure is accurately measured and the blood pressure is applied to the extremities, thereby increasing blood flow to the femoral region to produce blood clotting treatments. Although somewhat inadequate blood flow increases compared to conventional devices, blood flow can be significantly increased, which can be selectively.

• Proceedings of the Korean Institute of Information and Commucation Sciences Conference
• /
• 2017.05a
• /
• pp.171-174
• /
• 2017

One of the treatments and preventions of strokes such as ischemic stroke is to increase cerebral blood flow. This aims to minimize the size of the stroke by increasing the quantity of blood to the cerebral region circuitously. Several ways to increase cerebral blood flow are a therapy though drugs and through surgery. However these invasive method giving a burden to the patient, the problem of inducing a number of complications were noted. In this thesis, we propose a non-invasive cerebral blood flow augmentation device to compensate for the disadvantages of these invasive treatments. To compensate for the shortcomings of the existing cerebral blood flow device, apply a positive measure of the patient's extremities to measure the blood pressure of the patient's blood pressure and conduct a frontal injection of blood flow to increase blood flow. Although somewhat inadequate blood flow increases compared to conventional devices, blood flow can be significantly increased, which can be selectively.

• Applied Chemistry for Engineering
• /
• v.18 no.3
• /
• pp.199-204
• /
• 2007

Nanomedicine is a young and rapidly emerging field, which integrates clinical medicine with nanotechnology. Although the commercial nanomedicine is still in a fairly embryonic state, the recent advances in the nanotechnology-based therapeutics and diagnosis has changed the landscape of medicine. Bibliometric analysis shows a surge in research activity over the past decade. In this review, we have discussed some of the promising materials and their applications to this nascent field, such as carbon nanomaterials, polymeric drug delivery systems, and diagnostic imaging agents.

• Bulletin of Korea Environmental Preservation Association
• /
• s.397
• /
• pp.36-38
• /
• 2012

현대약품(대표 윤창현)은 지난 1965년 출범되어 지금까지도 국민들의 꾸준한 사랑을 받으며 잘 알려진 '현대물파스'로 시작한 의약품 전문기업이다. 현대약품은 47년의 지속적인 성장과 함께 현재 처방의약품은 물론, 일반의약품과 같은 의약품 사업과 기능성 식품, 기능성 음료 등의 건강기능식품, 그리고 의료기기에 이르기까지 국민건강증진을 위한 종합기업으로 성장하였다. 현대약품은 보다 체계화된 제품 안전성을 갖추는데 주력하기 위해, 전국 각 공장과 사업장에서 ISO9001, ISO14001, KOHSA18001, OHSAS18001 등의 인증을 획득, 제품의 안전성, 안정성과 제품 생산 표준화 등이 이루어지는 각종 기반을 마련하였다. 이를 통해 2008년 제약업계 최초 국가품질경영대회 제품안전경영 대통령상을 수상하는 영예도 얻게 되었다. 중앙연구소는 1984년도 설립되었으며 2009년 1월에는 경기바이오센터 합성신약연구소를 개소, 2011년 5월에는 용인에 신약 연구소를 준공하여 신약 및 개량신약 개발에 주력하고 있다. 현재까지도 지속적인 연구개발 및 기술 혁신 중심으로 21세기 첨단 의약품 생산에 필요한 다양한 연구에 매진하고 있다. 현대약품은 우수한 연구진과 최첨단 연구시설 확보를 통해 펩타이드 치료약물을 개발 생산하였다. 이어 이 기술을 바탕으로 기존의 거대시장 fmoc-아미노산을 대체하게 될 차세대 신물질로서 고체상 펩타이드 합성(solid phase peptide synthesis)의 원료물질인 Nsc-아미노산을 개발하였다. 전 사원 1년에 1일 이상의 봉사 활동을 의무적으로 실시하고 있으며 공장 직원 스스로 조직된 봉사 단체 두레회는 불우한 이웃의 시설을 유지, 보수하고 정이 그리운 어린이들과 함께 놀아주는 이웃들과 함께하는 작은 봉사 단체이다. 현대약품은 앞으로도 R&D투자를 활성화하여 우수의약품 개발에 전력을 다하고, 국민보건 향상에 책임을 완수하는 성실한 기업이 될 것이다.

• Journal of Chest Surgery
• /
• v.34 no.5
• /
• pp.377-385
• /
• 2001

배경: Cisplain과 같은 세포돗성 약제에 대한 내성은 폐암 치료 실패의 중요한 원인이다. 이러한 항암제에 대한 내성의 발생기전은 복잡하고 아직 완전히 알려져 있지 않지만 불량한 예후의 원인으로 생각된다. 특히 약제 내성이 발생한 환자의 경우 기존의 종양의 급속한 성장뿐 아니라 새로운 전이 병소가 급속히 발생 및 진단됨은 약제 내성을 가진 종양이 전이에의 용이성을 획득하는게 아닌가 의심케한다. 이를 규명하기 위해 Cisplatin에 내성을 지닌 비소세포폐암 세포주 H460/CISm이 전이 능력을 Cisplatin에 민감한 비소세포폐암 세로주 H460과 비교하고자 한다. 대상 및 방법: 약제 내성 세포주를 확보하기 위하여 H460세포에 cisplatin을 점차적으로 증가시켜 처리한 후 배양하였다. H460 세포와 H460/CIS 세로에서의 혈관신생인자와 성장관련인 자의 발현양상, gelatin zymography 분석 그리고 in vivo 실험으로 nude 마우스에서의 자발적 전이 능력의 차이를 비교하였다. 결과: H460 세포를 이식한 마우스에 폐에서는 종양이 형성되지 않았으나 H460/CIS세포를 이식한 마우스 10마리중 8마리에서 종양이 형성되었다. 또한 H460/CIS 세포주에서 전이 관련 유전자로 알려진 angiopoietin-1, vascular endothelial growth factor, basic fibroblast growth factor, matrix metalloproteinase 2 등이 더 발현되었고, 전이의 침습성을 유발하는 gelatinase의 활성이 증가된 것을 확인할 수 있었다. 결론: 본 여구 결과를 통해 cisplatin에 내성을 가진 비소세포폐암세포에서 전이 능력이 증가될 수 있다고 여겨지며 이러한 사실을 토대로 초기 비소세포폐암 환자의 수술 전 항암약물요법의 타당성에 대해서 이야기 하기 위해서는 많은 임상적 연구가 필요하리라 생각된다.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• v.8 no.1
• /
• pp.70-75
• /
• 2005

Crohn's disease of the perineum is notably resistant to treatment. We describe our experiences of tacrolimus ointment application in three patients with intractable perianal Crohn's disease. At the time of diagnosis patients showed anal fissure with ulcer, anal fistula, or perianal abscess, respectively. These lesions did not respond to steroid, metronidazole, mesalazine, or azathioprine, though the pediatric Crohn's disease activity index was markedly improved during the treatment period (4 to 12 months). Topical tacrolimus was applied and resulted in marked healing and a rapid granulation of cavity edges within 6 weeks to 3 months. Topical tacrolimus at a low dose shows a promise for the management of childhood perianal Crohn's disease. Further controlled studies are required to assess the efficacy and safety of this treatment.

• Korean Journal of Psychosomatic Medicine
• /
• v.15 no.1
• /
• pp.7-13
• /
• 2007

Antidepressants are used by substantial number of physicians as well as psychiatrists. Antidepressants are the mainstay of treatment of depression combined with physical illness, neuropathic pain, and various psychosomatic disorders. Antidepressants, especially TCA and SSRI, are superior to placebo in treating comorbid depression and pain of physical illness. Although it has been controversial whether the influence of depression on the risk and outcome of physical illness is true, antidepressants would provide more favorable prognosis and better quality of life for the patients with physical illness.